WallStreetZenWallStreetZen

NASDAQ: BDTX
Black Diamond Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BDTX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$79.8M
Current Profit Margin
0%

BDTX Return on Equity

Current Company
-72.9%
Current Industry
16.6%
Current Market
28.2%
BDTX's Return on Equity (-72.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BDTX announces earnings.

BDTX Return on Assets

Current Company
-53.8%
Current Industry
3.1%
BDTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BDTX Return on Capital Employed

Current Company
-63.49%
Current Industry
-43.5%
BDTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BDTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BDTX$0.00-$79.39M-$79.79MN/AN/A
ADAP$18.36M-$151.35M-$163.41M-18.58%N/A
INO$717.07k-$120.74M-$124.94M-53.15%N/A
CRBU$33.40M-$109.36M-$115.26M+119.99%N/A
MGNX$43.36M-$9.66M-$23.24M-7.80%N/A
View Top Biotech Stocks

Black Diamond Therapeutics Earnings & Revenue FAQ

What were BDTX's earnings last quarter?

On Invalid Date, Black Diamond Therapeutics (NASDAQ: BDTX) reported Q1 2024 earnings per share (EPS) of -$0.35, up 38.6% year over year. Total Black Diamond Therapeutics earnings for the quarter were -$18.23 million. In the same quarter last year, Black Diamond Therapeutics's earnings per share (EPS) was -$0.57.

If you're new to stock investing, here's how to buy Black Diamond Therapeutics stock.

What was BDTX's earnings growth in the past year?

As of Q2 2024, Black Diamond Therapeutics's earnings has grown year over year. Black Diamond Therapeutics's earnings in the past year totalled -$79.79 million.

What was BDTX's revenue last quarter?

On Invalid Date, Black Diamond Therapeutics (NASDAQ: BDTX) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Black Diamond Therapeutics's revenue was $0.00.

What was BDTX's revenue growth in the past year?

As of Q2 2024, Black Diamond Therapeutics's revenue has grown null year over year. Black Diamond Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.